Below you can find consensus from equity research analysts that currently cover Fluidra's stock (updated on a monthly basis).
FY 2023 (in €M):
| Metric | Min | Max | Average | Contr. |
|---|---|---|---|---|
| Sales | 2,006 | 2,159 | 2,084 | 16 |
| Adjusted EBITDA | 416 | 453 | 434 | 15 |
| Adjusted EBITA | 330 | 365 | 347 | 9 |
| Cash Net Profit | 186 | 228 | 204 | 13 |
| Cash EPS | 0,97 | 1,16 | 1,06 | 13 |
| Net Working Capital | 367 | 510 | 437 | 15 |
| Net Debt | 1,083 | 1,291 | 1,180 | 15 |
FY 2024 (in €M):
| Metric | Min | Max | Average | Contr. |
|---|---|---|---|---|
| Sales | 1,880 | 2,322 | 2,159 | 16 |
| Adjusted EBITDA | 392 | 535 | 472 | 15 |
| Adjusted EBITA | 364 | 446 | 391 | 9 |
| Cash Net Profit | 179 | 270 | 235 | 12 |
| Cash EPS | 0,93 | 1,41 | 1,23 | 12 |
| Net Working Capital | 344 | 534 | 434 | 15 |
| Net Debt | 911 | 1,261 | 1,057 | 15 |
* Data as of 27.09.2023
Notes:
- A total of 18 analysts cover Fluidra. The consensus presented above includes figures from those analysts who have published updated estimates in the last 6 months (16 analysts).
- The metrics compiled above are consistent with Fluidra's reporting metrics. Fluidra does not alter the figures in any way.